Diabetes Dialogue: "Second-Generation" Obesity Medications, with W. Timothy Garvey, MD
June 28th 2023W. Timothy Garvey, MD, sits down to discuss the results of SURMOUNT-2, the ongoing revolution of antiobesity medications, and why he is concerned over the growing prevalence of online weight loss clinics
Read More
Diabetes Dialogue: Improving Implementation of New Technology, with Cari Berget, RN, MPH
June 26th 2023Hosts are joined by Cari Berget, RN, MPH, for a deep dive into her efforts to improve the implementation of the latest diabetes technologies in real-world settings through her role as a director of the PANTHER Program.
Read More
Diabetes Dialogue: Managing & Addressing Mental Health Needs in Diabetes
June 25th 2023Often overlooked and unrecognized, the mental health challenges accompanying type 1 diabetes are becoming a focal point of discussion for many in the field, including Mark Heyman, PhD, who joined Diana Isaacs, PharmD, and Natalie Bellini, DNP, for a special ADA 2023 edition of Diabetes Dialogue.
Read More
Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD
June 25th 2023At ADA 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sat down with ADCES President-Elect Jane Dickinson, RN, PhD, to discuss her work to address shortfalls of the current language used in the management of diabetes.
Read More
Diabetes Dialogue: Diabetic Foot Ulcers and Social Determinants of Health
June 25th 2023At ADA 2023, hosts sit down with Gary Rothenberg, DPM, to discuss awareness and management of diabetic foot ulcers as well as how social determinants of health can influence risk and outcomes for patients with diabetes.
Read More
Exploring SGLT2 Inhibitor Benefits in Chronic Kidney Disease
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP:-BC, interview Dr Robert Busch, to explore the advantages of SGLT2 inhibitors in chronic kidney disease, cardiovascular health, and their potential to improve overall patient outcomes.
Read More
Exploring the Benefits of SGLT2 Inhibitors in Chronic Kidney Disease
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP:-BC, interview Dr Robert Busch, to explore the advantages of SGLT2 inhibitors in chronic kidney disease, cardiovascular health, and their potential to improve overall patient outcomes.
Read More
Emerging Evidence on the Treatment of Obesity
In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.
Read More
Emerging Evidence in the Treatment of Obesity
In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.
Read More
Diabetes Dialogue: What to Know about the iLet Bionic Pancreas
May 26th 2023As a follow-up to an episode earlier this year and the FDA clearances of the technology that forms the iLet Bionic Pancreas, hosts sat down in the MJH Life Sciences studio for a special edition recording to explore the implications of the clearance, dispel misconceptions surrounding the system, and hypothesize about the future of this technology in people with diabetes.
Read More
Supporting Adolescents and Young Adults in Managing Type 1 Diabetes
In this episode of MEDcast, Dr Julia Blanchette joins Diana Isaacs, PharmD, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, discuss strategies to empower young adults with the skills and resources necessary to effectively manage type 1 diabetes and maintain a healthy lifestyle.
Read More
Addressing Challenges of Type 1 Diabetes Self-Management Among Young Adults
Diabetes care experts discuss practical strategies to help young adults with type 1 diabetes transition from pediatric to adult endocrinology care, and how families can support them during this transition.
Read More
Diabetes Dialogue: Breaking Down AACE's New Type 2 Diabetes Management Algorithms
May 18th 2023In this episode, hosts sit down for an in-depth discussion of the 11 person-centered algorithms for clinical decision-making featured in the AACE's 2023 Comprehensive Type 2 Diabetes Management Algorithm.
Read More
Financial Toolkit for Young Adults with Type 1 Diabetes
Dr Julia Blanchette explains how a micro video toolkit developed by her team can help young adults alleviate the financial stress of type 1 diabetes.
Read More
Coping With Healthcare Finances and Other Challenges as a Young Adult with Type 1 Diabetes
Julia Blanchette, PhD, RN; Natalie Bellini, DNP, FNP-BC; and Diana Isaacs, PharmD, BC-ADM, CDCES discuss the challenges young adults with type 1 diabetes encounter, including managing their healthcare finances.
Read More
Latest Advances in Automated Insulin Delivery
Dr Julia Blanchette highlights some of the latest advancements in automated insulin delivery systems that can aid in the self-management of type 1 diabetes.
Read More
Diabetes Dialogue: Breaking Down the Medtronic 780G Approval, with Robert Vigersky, MD
May 12th 2023In this episode, hosts sit down with Robert Vigersky, MD, chief medical officer of Medtronic Diabetes, for a discussion around the MiniMed 780G, including use, exclusive features, and how patients can obtain the new system.
Read More
Diabetes Dialogue: SURMOUNT-2 Reaction, Omnipod GO, and Verapamil for T1D
May 3rd 2023In this episode, hosts offer their reaction to topline data from the SURMOUNT-2 trial examining tirzepatide for weight management in T2D, the FDA's clearance of the Omnipod GO device, and results of the CLVer trial.
Read More
Advances in the Treatment of Diabetic Kidney Disease
On this episode of MEDcast, Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC are joined by Dr George Bakris to discuss the latest advances in treatments and comprehensive care for patients with diabetes and chronic kidney disease.
Read More
Need for Early Detection of Diabetic Kidney Disease
Drs Diana Isaacs and Natalie Bellini emphasize the need for early detection of diabetic kidney disease through the monitoring of cardiometabolic risk factors.
Read More
Comprehensive Care for Patients with Diabetic Kidney Disease
George Bakris, MD, shares best practices for co-management and providing comprehensive care for patients with diabetic kidney disease.
Read More
Clinical Data on Finerenone in Diabetic Kidney Disease
Dr George Bakris reviews the clinical trial data for finerenone and provides insights on treatment selection, including the potential benefits of combination therapy with finerenone and SGLT2 inhibitors, in managing diabetic kidney disease.
Read More
Risk Factors and Impact of Diet and Lifestyle on Progression of Diabetic Kidney Disease
Dr George Bakris elaborates on the risk factors, monitoring, treatment objectives, and the impact of diet and exercise in preventing the progression of diabetic kidney disease.
Read More
Diabetes Dialogue: News on Abbott Readers & CMS Expansion of CGM Availability
April 19th 2023Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down to discuss the implications of increased CGM access through a recent CMS expansion and take a deep dive into the latest Abbott news, including dispelling misconceptions surrounding the recall announcement.
Read More
Strategies for Early Diagnosis of Type 1 Diabetes in Children
Fran Cogen, MD, joins Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, on this MEDcast episode to stress the significance of early detection for type 1 diabetes. The conversation covers screening protocols and options, as well as emerging treatments that can delay the onset of the disease.
Read More
Key Takeaways for Screening Children and Adults for Type 1 Diabetes
Drs Diana Isaacs and Natalie Bellini summarize the key takeaways on screening for pediatric and adult-onset type 1 diabetes and strategies to improve screening.
Read More
Treatments to Delay Progressing of T1D
An expert pediatric endocrinologist discusses best practices for referring patients to a specialist in type 1 diabetes, as well as the potential of new therapies in delaying the progression of the disease.
Read More
Antibodies to Screen for Type 1 Diabetes
Dr Fran Cogen discusses the screening of autoantibodies for type 1 diabetes and provides insights on how to interpret the results of the screening tests.
Read More
Importance of Screening and Early Detection of Type 1 Diabetes
Dr Fran Cogen emphasizes the importance of early screening and detection of type 1 diabetes to prevent the adverse health effects of diabetic ketoacidosis.
Read More
Diabetes Dialogue: 10 Years of SGLT2s, Insulin for All, and Pemvidutide
March 29th 2023In this episode, hosts celebrate the 10-year anniversary of the approval of the first SGLT2 inhibitor, discuss announcements related to insulin pricing, and take a deep dive into 24-week data from the MOMENTUM trial.
Read More